News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
180 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (14535)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
1 (166)
2 (223)
3 (215)
4 (224)
5 (155)
8 (199)
9 (247)
10 (271)
11 (209)
12 (162)
15 (180)
16 (222)
17 (157)
18 (181)
19 (102)
22 (166)
23 (169)
24 (164)
25 (121)
26 (94)
30 (155)
31 (180)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
8
9
10
11
12
15
16
17
18
19
22
23
24
25
26
30
31
Drug Development
Summit Therapeutics Completes Enrollment Of Phaseout DMD, A Phase II Clinical Trial Of Ezutromid In Patients With DMD
May 15, 2017
·
6 min read
Drug Development
Imara Receives Rare Pediatric Disease Designation From FDA For Lead Product Candidate IMR-687 For Sickle Cell Disease
May 15, 2017
·
4 min read
Business
twoXAR Appoints Brian Moriarty As CFO And Jill Jene, PhD, As SVP, Business Development
May 15, 2017
·
2 min read
Drug Development
Aurinia Reports First Quarter 2017 Financial Results, Announces Initiation Of Phase III Aurora Clinical Trial, And Provides Operational Highlights
May 15, 2017
·
1 min read
Lone Star Bio
Castle Biosciences Release: Study Demonstrates Significant And Risk-Appropriate Clinical Impact Of DecisionDx-Melanoma Test Results On Patient Management Decisions
May 15, 2017
·
4 min read
Biotech Bay
Intuitive Surgical Reports New Employee Option Grants For May 2017
May 15, 2017
·
2 min read
Drug Development
OSE Immunotherapeutics Presents New Data On Anti-SIRPa (Effi-DEM), The Checkpoint Inhibitor Blocking Pro-Tumor And Suppressor Myeloid Cells At “Advances In Immuno-Oncology Congress,” London, May 15-16, 2017
May 15, 2017
·
6 min read
eClinicalHealth Limited Release: A Record Year For The Clinpal Team & Remote Research Thought Leadership
May 15, 2017
·
2 min read
Drug Development
Syros Pharma Announces First Patient Dosed In Phase I Clinical Trial Of SY-1365, Its First-In-Class Selective CDK7 Inhibitor, In Patients With Advanced Solid Tumors
May 15, 2017
·
6 min read
BioMidwest
Great Basin Scientific Obtains Release Of $1.36 Million Of Restricted Cash From Series B Convertible Notes
May 15, 2017
·
3 min read
Previous
7 of 18
Next
